# Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely

> **NCT02545127** · PHASE2 · TERMINATED · sponsor: **Ferring Pharmaceuticals** · enrollment: 4 (actual)

## Conditions studied

- Preterm Delivery
- Inadequate Milk Production

## Interventions

- **DRUG:** Merotocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02545127
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-28
- **Primary completion:** 2022-11-11
- **Final completion:** 2022-11-11
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** The trial was prematurely terminated. Termination was not because of safety concerns but due to slow recruitment.
- **Last updated:** 2024-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02545127

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02545127, "Merotocin in Mothers With Inadequate Milk Production and Infants Delivered Prematurely". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02545127. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*